Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Artificial Intelligence (AI) In Clinical Trials Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The artificial intelligence (AI) in clinical trials market size has expanded significantly in recent years. It is projected to grow from $10.11 billion in 2025 to $14.11 billion in 2026, at a compound annual growth rate (CAGR) of 39.6%. This historical growth can be attributed to several factors: an increase in clinical trial failure rates, greater R&D investment by pharmaceutical companies, the expansion of clinical data volumes, the demand for quicker drug approvals, and inherent inefficiencies in traditional trial processes.
The artificial intelligence (AI) in clinical trials market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $47.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 35.3%. This expansion during the forecast period can be linked to the increased adoption of decentralized clinical trials, growing regulatory acceptance of AI technologies, advancements in precision medicine research, the rising demand for more cost-efficient trials, and progress in healthcare analytics. Noteworthy trends for the forecast period include AI-powered optimization of trial designs, modeling for predictive patient enrollment, site selection guided by data, automated clinical outcome analysis, and adaptive platforms for trial execution.
Download A Free Sample Report For Comprehensive Market Insights:
Artificial Intelligence (AI) In Clinical Trials Market Demand Drivers: What Is Fueling Industry Growth?
The escalating requirement to contain expenditures associated with clinical trials is anticipated to drive the expansion of artificial intelligence in the clinical trial market in the forthcoming period. Clinical trials are defined as investigative studies utilized to assess medical, surgical, or behavioral interventions in individuals, with their inherent costs encompassing both research activities and patient care. Given the naturally high costs involved in drug development and other clinical trial processes, artificial intelligence serves to enable superior drug discovery, more effectively designed and safer clinical trials, and enhanced patient outcomes at reduced costs. For instance, in February 2023, data reported by Genetic Engineering and Biotechnology News, a US-based platform delivering current information on genetic engineering and biotechnology, revealed that the expense of developing a new drug among the top 20 global biopharma companies surged by 15% from $298 million in 2022 to approximately $2.3 billion in 2023, a figure inclusive of costs incurred during drug development through clinical trials. Furthermore, in January 2023, a report issued by the National Bureau of Economic Research (NBER), a US-based non-profit economic research organization, indicated that the integration of AI within the next five years is expected to generate significant healthcare cost savings, ranging from 5 to 10% of healthcare spending, amounting to approximately $200 billion to $360 billion in annual savings. Thus, the increasing necessity to mitigate clinical trial costs will significantly propel artificial intelligence in the clinical trial market.
Artificial Intelligence (AI) In Clinical Trials Market Segment Breakdown: Which Categories Generate The Most Revenue?
The artificial intelligence (AI) in clinical trials market covered in this report is segmented –
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users
Subsegments:
1) By Software: AI-driven Analytics Platforms, Data Management Tools, Patient Recruitment Solutions, Predictive Modeling Software
2) By Services: Consulting Services, Data Annotation And Labeling Services, Custom AI Model Development, Implementation And Integration Services
Artificial Intelligence (AI) In Clinical Trials Market Trends Reshaping Industry Growth
Leading companies in the artificial intelligence in clinical trials market are concentrating on developing innovative technologies, such as AI feasibility and recruitment platforms. These platforms are systems that leverage artificial intelligence to evaluate the viability and potential success of clinical trials, while also supporting the efficient recruitment of suitable participants. For example, in June 2023, a US-based research provider company unveiled ‘ObjectiveScreen’. This AI-powered feasibility and recruitment platform improves clinical trial performance and results by enhancing patient identification, prequalification, and retention processes. ObjectiveScreen allows for direct connectivity between clinical trial sites and patients’ electronic health records (EHRs). The AI platform additionally fosters patient engagement by simplifying and streamlining appointment scheduling and communication processes.
Artificial Intelligence (AI) In Clinical Trials Market Key Players And Strategic Industry Positioning
Major companies operating in the artificial intelligence (AI) in clinical trials market are Medable Inc.; PathAI inc.; Saama Technologies Inc.; TriNetX LLC; SymphonyAI Summit Inc.; Aktana; Nference Inc.; Insilico Medicine Inc.; Vineti Inc.; Innoplexus AG; Healx; AiCure Inc.; MEDIAN Technologies SA; Owkin Inc.; Science 37; Ardigen SA; Cyft Inc.; Unlearn.AI Inc.; Mendel AI; Deep Lens Inc.; Antidote Technologies Inc.; Arterys Inc.; Euretos BV; Halo Health Systems Inc.; Trials.AI Inc.; Transparency Life Sciences; BioAge Labs Inc.; Wave Life Sciences Ltd.; BioSymetrics Inc.
Access The Complete Artificial Intelligence (AI) In Clinical Trials Market Report:
#Artificial Intelligence (AI) In Clinical Trials Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
